Key Dates

Related Announcements

• May 20, 2024 - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed). See NOFO RFA-DA-25-056

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice alerts applicants of the early expiration of RFA-DA-25-056 "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)". The request for applications, RFA-DA-25-056, will be expired, effective immediately. No further applications will be accepted for consideration under this NOFO.

A new NOFO to support “Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)” will be issued to correct forms packages. Applications for the new NOFO will be due early February 2025.

Applicants are encouraged to consider applying to the new NOFO (expected to be published in early January 2025): RFA-DA-25-086, "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)".

Inquiries

Please direct all inquiries to:

Tam Nguyen, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-451-1203
Email: [email protected]